Synthego Snags $110 Million in Series C to Advance Vision of Making CRISPR Technology More Available 글 내용 전체보기
With Money and Equity Changing Hands, Innate Pharma and AstraZeneca Move Deeper into an Immuno-oncology Pact 글 내용 전체보기
10 Months After Abandoning Neuroscience R&D, Pfizer Launches CNS Company Cerevel Therapeutics 글 내용 전체보기